Unknown

Dataset Information

Angiotensin-converting enzyme inhibitors and risk of age-related macular degeneration in individuals with hypertension.


ABSTRACT:

Aims

Several observational studies have examined the potential protective effect of angiotensin-converting enzyme inhibitor (ACE-I) use on the risk of age-related macular degeneration (AMD) and have reported contradictory results owing to confounding and time-related biases. We aimed to assess the risk of AMD in a base cohort of patients aged 40 years and above with hypertension among new users of ACE-I compared to an active comparator cohort of new users of calcium channel blockers (CCB) using data obtained from IQVIA Medical Research Data, a primary care database in the UK.

Methods

In this study, 53 832 and 43 106 new users of ACE-I and CCB were included between 1995 and 2019, respectively. In an on-treatment analysis, patients were followed up from the time of index drug

SUBMITTER: Subramanian A 

PROVIDER: S-EPMC9541840 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature